Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
Open-market buys, last 90 days
$104,806
in 9 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 55 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-12-30 CAUWENBERGH GEERT President & CEO Grant or award +2,000 $0.73 $1K 52,583
2016-12-23 CAUWENBERGH GEERT President & CEO Grant or award +3,000 $0.72 $2K 4,500
2016-12-22 CAUWENBERGH GEERT President & CEO Grant or award +3,000 $0.75 $2K 53,583
2016-12-16 CAUWENBERGH GEERT President & CEO Grant or award +33,333 $0.90 $30K 50,583
2016-12-16 CAUWENBERGH GEERT President & CEO Grant or award · Common stock warrant +33,333 33,333
2016-12-16 Pavco Pamela Chief Development Officer Grant or award +11,111 $0.90 $10K 17,173
2016-12-16 Pavco Pamela Chief Development Officer Grant or award · Common stock warrant +11,111 11,111
2016-02-10 Lockshin Curtis Director Grant or award · Stock option (right to buy) +16,666 16,666
2016-02-10 Dorman H. Paul Director Grant or award · Stock option (right to buy) +16,666 16,666
2016-02-10 Brownlie Keith L Director Grant or award · Stock option (right to buy) +16,666 16,666
2016-02-10 Bitterman Robert J Director Grant or award · Stock option (right to buy) +16,666 16,666
2016-02-10 CAUWENBERGH GEERT President & CEO Grant or award · Stock option (right to buy) +133,000 133,000
2016-02-10 Pavco Pamela Chief Development Officer Grant or award · Stock option (right to buy) +66,000 66,000
2016-02-10 Kontulis Caitlin Secretary & Dir. of Finance Grant or award · Stock option (right to buy) +20,000 20,000
2015-06-22 CAUWENBERGH GEERT President & CEO Option exercise +35,000 $0.46 $16K 172,500
2015-06-22 CAUWENBERGH GEERT President & CEO Option exercise · Overallotment purchase right −35,000 0
2015-06-02 Pavco Pamela Chief Development Officer Grant or award +12,500 $0.40 $5K 33,718
2015-06-02 Pavco Pamela Chief Development Officer Grant or award · Overallotment purchase right +6,250 6,250
2015-06-02 Pavco Pamela Chief Development Officer Grant or award · Common stock purchase warrant +6,250 6,250
2015-06-02 Lockshin Curtis Director Grant or award +12,000 $0.40 $5K 13,000

Page 10 of 13 · 258 trades